C2A Security's EVSec Risk Management and Automation Platform Gains ... 2024-03-28
C2A Security’s EVSec Risk Management and Automation Platform Gains ...
Source: pr-inside.com
Estee Yaari News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Estee Yaari. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Estee Yaari Today - Breaking & Trending Today
C2A Security Announces New Technology Collaboration with Siemens
/PRNewswire/ -- C2A Security, developers of the mobility-centric DevSecOps Platform for car makers, suppliers, and EV charging companies, announced that it has...
Source: prnewswire.com
Evvo Labs Selects C2A Security as its Strategic Partner for Cybersecurity, Boosting their Portfolio to EV Charging Companies
/PRNewswire/ -- C2A Security, the only DevSecOps Platform for car makers and mobility companies, announced it has been selected by Evvo Labs, a leading IT...
Source: prnewswire.com
Oramed Issues Letter to Shareholders with Updates on Oral Insulin and COVID-19 Vaccine
Share this article Share this article NEW YORK, May 25, 2021 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, is pleased to provide the following Letter to Shareholders from Chief Executive Officer Nadav Kidron. Dear Shareholders, I'm excited to share with you significant milestones we have achieved over the past few months. Our oral delivery platform technology could apply to a range of proteins and disease modalities, and we expect over time to have a r...
Source: prnewswire.com
Oramed Pharmaceuticals and Oravax Medical to be Featured in Alliance Global Partners' Grand Rounds: A Webinar in Biotech and Specialty Pharma
Share: NEW YORK, April 21, 2021 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced that CEO Nadav Kidron will be featured in a live webinar titled Grand Rounds: a Webinar in Biotech and Specialty Pharma hosted by James Molloy, Managing Director of Equity Research, Biotechnology and Specialty Pharmaceuticals at Alliance Global Partners on Monday, April 26, 2021 at 11:00 Eastern. Mr. Kidron, along with Premas Biotech Co-Founder and M...
Source: benzinga.com